PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1401127
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1401127
Global Endoscopic Vessel Harvesting Market Size to Grow at Steady CAGR of 3.58% During 2023-2029, Reaching USD 623.45 Million by 2029
Global Endoscopic Vessel Harvesting Market is flourishing because of growing preference for minimally invasive surgery and increasingly rapid adoption of technological advancements.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Endoscopic Vessel Harvesting Market size at USD 504.8 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects Global Endoscopic Vessel Harvesting Market size to grow at a CAGR of 3.58% reaching a value of USD 623.45 million by 2029. Major growth drivers for the Global Endoscopic Vessel Harvesting Market include growing inclination toward minimally invasive harvesting procedures and the increasing prevalence of cardiovascular diseases. Notably, the expanding healthcare sector, a growing geriatric population across the regions, and increasing applications in emerging economies also contribute to the overall market growth. It is projected that by 2050, the worldwide number of individuals aged 65 years or above will surpass twice the number of children under the age of 5 and will be comparable to the number of children under the age of 12. Also, a study published in the Journal of Thoracic Disease in March 2021 revealed that patients undergoing minimally invasive vein or vessel harvesting were discharged four days earlier compared to those undergoing open harvesting procedures, indicating the growing advantages of minimally invasive harvesting methods that are expected to contribute to market growth. However, high cost of endoscopic vessel harvesting devices and reimbursement challenges are anticipated to restrain the overall market growth during the period in analysis.
Opportunity - Growing awareness of endoscopic vessel harvesting
The use of endoscopic vessel harvesting (EVH) devices is not limited to cardiac and vascular surgery but extends to other medical procedures like plastic surgery or organ transplantation. The diversification, as a result, broadens the market potential and clientele for EVH devices. Additionally, the incorporation of artificial intelligence (AI) in surgical optimization, including graft selection and procedural guidance, presents significant growth opportunities. The adoption of telemedicine and remote surgery can further propel market growth, enabling surgeons to perform procedures from remote locations. Collaborations with regenerative medicine open new avenues for applying harvested grafts in tissue engineering and organ transplantation. The integration of patient-specific data enhances the potential for individualized surgical approaches, contributing to improved transplant selection. Overall, the evolving awareness of the versatile applications of EVH devices signifies a growing understanding within the medical community, expanding their role beyond traditional surgical domains.
Impact of COVID-19 on Global Endoscopic Vessel Harvesting Market
COVID-19 pandemic adversely affected the Global Endoscopic Vessel Harvesting Market. It led to decline in hospital and clinic visits for cardiac care, affecting the demand for procedures like endoscopic vessel harvesting in the early stages of the pandemic. Research cited in an article from the Journal of the American College of Cardiology in August 2022 indicated substantial reductions in hospital admissions for cardiovascular diseases during the pandemic. Also, studies on population-level cardiovascular disease mortality in various countries consistently indicated declines. Consequently, the overall cardiovascular disease market, including endoscopic vessel harvesting, encountered significant disruptions in the initial stages of the pandemic. However, with the easing of the pandemic, cardiac care has returned to normal, and the Global Endoscopic Harvesting Market is expected to witness steady growth over the forecast period.
Global Endoscopic Vessel Harvesting Market - By Application
Based on application, the Global Endoscopic Vessel Harvesting Market is bifurcated into Coronary Artery Disease and Peripheral Artery Disease segments. The coronary artery disease application segment is expected to hold a higher share in the Global Endoscopic Vessel Harvesting Market during the forecast period. Coronary artery disease (CAD), characterized by the narrowing or blockage of coronary arteries due to plaque buildup, is witnessing growth primarily driven by the escalating prevalence of CAD and the growing geriatric population. According to a July 2022 article on PubMed Central, CAD, also known as coronary heart disease, often leads to conditions such as angina, myocardial infarction (MI), and heart failure, contributing significantly to cardiovascular diseases. This high burden positions the studied segment for growth during the forecast period. Healthdirect Australia's June 2022 review identifies coronary heart disease as the leading cause of death in Australia, with risk factors including smoking, excessive alcohol consumption, lack of exercise, social isolation, and obesity. This burden of CAD globally is expected to drive the adoption of endoscopic vessel harvesting procedures. Additionally, the increased risk of CAD with age, coupled with a growing geriatric population globally, further propels segment growth. In essence, the cumulative impact of factors such as the increasing burden of CAD, rapidly aging population across the world, and heightened research investments is expected to significantly boost the growth of the segment.
Global Endoscopic Vessel Harvesting Market - By Region
The in-depth research report on the Global Endoscopic Vessel Harvesting Market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America region holds the highest share in the Global Endoscopic Vessel Harvesting Market, due to the increasing incidence of non-communicable diseases, such as coronary artery disease and peripheral arterial disease, coupled with a growing geriatric population. Statistics Canada reported in July 2022 that approximately 18.8% of Canada's population, around 7,330,605 individuals, were aged 65 or older, making them more susceptible to peripheral arterial diseases and thereby increasing the demand for endoscopic vessel harvesting procedures. In the United States, where an estimated 8.5 million adults were affected by peripheral arterial disease, constituting a 7% prevalence, the demand for related treatments is escalating. These factors, encompassing the rising burden of coronary artery disease and peripheral arterial disease alongside an increasing geriatric population, are expected to propel segment growth in the region.
Competitive Landscape
Major players operating in the Global Endoscopic Vessel Harvesting Market include Getinge, Terumo, Livanova, Karl Storz, Saphena Medical, Cardio Medical, Medtronic, Olympus, Fujifilm, Arthrex, Aesculap, MedX X-Change, Vessel Closure Systems, Vascular Technologies, and SurgiQuest. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Endoscopic Vessel Harvesting Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Endoscopic Vessel Harvesting Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.